Erratum to: BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain
暂无分享,去创建一个
L. David | S. Bailly | J. Feige | Nicolas Ricard | M. Bidart | C. Mallet | M. Samson | E. Tillet | Mariela Subileau | S. Levet | N. Ricard
[1] L. David,et al. BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain , 2012, Cellular and molecular life sciences : CMLS.
[2] A. Nohe,et al. Bone morphogenetic proteins: a critical review. , 2011, Cellular signalling.
[3] D. Langleben,et al. Bone morphogenic protein-9 stimulates endothelin-1 release from human pulmonary microvascular endothelial cells: a potential mechanism for elevated ET-1 levels in pulmonary arterial hypertension. , 2010, Microvascular research.
[4] D. Brown,et al. The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[5] G. Lesca,et al. Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations. , 2010, Blood.
[6] M. D. de Caestecker,et al. BMP signaling in vascular development and disease. , 2010, Cytokine & growth factor reviews.
[7] J. Ridgway,et al. ALK1 signaling regulates early postnatal lymphatic vessel development. , 2010, Blood.
[8] P. Knaus,et al. BMPs: From Bone to Body Morphogenetic Proteins , 2010, Science Signaling.
[9] N. Solban,et al. ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth , 2010, Molecular Cancer Therapeutics.
[10] M. Goumans,et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis , 2010, The Journal of experimental medicine.
[11] Kohei Miyazono,et al. Bone morphogenetic protein receptors and signal transduction. , 2010, Journal of biochemistry.
[12] P. Knaus,et al. Recent advances in BMP receptor signaling. , 2009, Cytokine & growth factor reviews.
[13] J. Christian,et al. Site-specific Cleavage of BMP4 by Furin, PC6, and PC7* , 2009, The Journal of Biological Chemistry.
[14] L. David,et al. Emerging role of bone morphogenetic proteins in angiogenesis. , 2009, Cytokine & growth factor reviews.
[15] J. Inman,et al. Bmc Cell Biology a Rapid and Sensitive Bioassay for the Simultaneous Measurement of Multiple Bone Morphogenetic Proteins. Identification and Quantification of Bmp4, Bmp6 and Bmp9 in Bovine and Human Serum , 2022 .
[16] L. David,et al. Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.
[17] Gerard C Blobe,et al. Role of transforming growth factor-beta superfamily signaling pathways in human disease. , 2008, Biochimica et biophysica acta.
[18] A. Goldberg,et al. Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle* , 2008, Journal of Biological Chemistry.
[19] M. V. Dinther,et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.
[20] L. David,et al. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.
[21] R. Kamijo,et al. Purification and identification of a BMP-like factor from bovine serum. , 2006, Biochemical and biophysical research communications.
[22] D. Keene,et al. The Prodomain of BMP-7 Targets the BMP-7 Complex to the Extracellular Matrix* , 2005, Journal of Biological Chemistry.
[23] Mallika Singh,et al. Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors* , 2005, Journal of Biological Chemistry.
[24] W. N. Pappano,et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. J. Dumont,et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat , 2003, Gene Therapy.
[26] A. Economides,et al. 0163-769X/03/$20.00/0 Endocrine Reviews 24(2):218–235 Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/er.2002-0023 Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton , 2022 .
[27] Mallika Singh,et al. An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis , 2003, Nature Biotechnology.
[28] K. Ishimura,et al. Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. , 2003, Biochimica et biophysica acta.
[29] D. Constam,et al. Extraembryonic proteases regulate Nodal signalling during gastrulation , 2002, Nature Cell Biology.
[30] M. Goumans,et al. Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells , 2002, Circulation.
[31] P. ten Dijke,et al. Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.
[32] Dean Y. Li,et al. Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.
[33] J. Blusztajn,et al. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. , 2000, Science.
[34] R. Thies,et al. Bone Morphogenetic Protein-9 , 2000, The Journal of Biological Chemistry.
[35] P. Donahoe,et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Neben,et al. Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free cultures , 1999, Leukemia.
[37] D. Constam,et al. Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases , 1999, The Journal of cell biology.
[38] G. Thomas,et al. BMP‐4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development , 1998, The EMBO journal.
[39] E. Chambaz,et al. Thrombospondins selectively activate one of the two latent forms of transforming growth factor-beta present in adrenocortical cell-conditioned medium. , 1995, Endocrinology.
[40] V. Rosen,et al. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. , 1995, Endocrinology.
[41] H. D. Moss. Hereditary hemorrhagic telangiectasia. , 1987, General dentistry.